anti-CD4 monoclonal antibody (Fraunhofer Institute for Cell Therapy and Immunology)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-CD4 monoclonal antibody (Fraunhofer Institute for Cell Therapy and Immunology)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionT-cell surface antigen CD4 modulators
TargetsT-cell surface antigen CD4
Therapy Area/IndicationsGraft vs Host Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFraunhofer-Institute fur Zelltherapy und Immunologie
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFraunhofer-Institute fur Zelltherapy und Immunologie
Active IndicationsN/A
Inactive IndicationsGraft vs Host Disease

Other Information

ATC CodeN/A
Related LinksN/A